CLEVELAND CLINIC CLEVELAND – COVID-19 is known primarily as a respiratory disease, with symptoms that include cough, shortness of breath, and, in severe cases, acute respiratory distress syndrome and pneumonia. Now, researchers from Cleveland Clinic’s Department of Biomedical Engineering note in a recent review that infection with the coronavirus may also affect the central nervous system and...
Tag: <span>COVID-19</span>
Post
What scientists are learning about COVID-19 and the brain
by Sanford Burnham Prebys Medical Discovery Institute The scientists found that SARS-CoV-2 (red) primarily infects brain cells called choroid plexus cells (blue), which are part of the brain’s protective blood-brain barrier. Credit: Sanford Burnham Prebys Medical Discovery Institute We caught up with cell biologist Anne Bang, who recently teamed up with her husband to study how...
Post
NUS researchers finds best combination of available therapies against COVID-19
NATIONAL UNIVERSITY OF SINGAPORE IMAGE: (FROM LEFT) PROFESSOR DEAN HO, ASSOCIATE PROFESSOR EDWARD CHOW, AND DR AGATA BLASIAK WORKED WITH THEIR COLLABORATORS TO DERIVE AN OPTIMAL COMBINATION OF AVAILABLE THERAPIES AGAINST SARS-COV-2 USING THE IDENTIF.AI PLATFORM CREDIT: NATIONAL UNIVERSITY OF SINGAPORE A team of researchers from the National University of Singapore (NUS) has utilised a ground-breaking artificial...
Post
Why COVID outbreaks look set to worsen this winter
It’s too soon to say whether COVID is seasonal like the flu — but where clusters aren’t under control, infections will continue to swell. Smriti Mallapaty Changing seasons might affect the transmission of SARS-CoV-2, but researchers say it’s too early to tell.Credit: Beata Zawrzel/NurPhoto/Getty Winter is fast approaching in the Northern Hemisphere, and researchers warn...
Post
Vaccine candidate protects against COVID-19 and yellow fever
by KU Leuven A lab worker holds frozen virus samples at the KU Leuven Rega Institute. Credit: Layla Aerts for KU Leuven Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results published today...
Post
Virus induced lymphocytes show promise for COVID-19 and future pandemics
By Sally Robertson, B.Sc.;Nov 30 2020 Researchers in the United States have conducted a study demonstrating the potential of a novel therapeutic approach to treating coronavirus disease 2019 (COVID-19). The therapy augments the body’s T cell response to the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by providing a boost of rapidly expanded virus-specific T...
Post
Female reproductive hormones may be protective against COVID-19
By Sally Robertson, B.Sc.,Nov 29 2020 In an article recently published in Trends in Endocrinology & Metabolism, Graziano Pinna from the University of Illinois in Chicago outlines some of the evidence suggesting that female reproductive hormones may play a role in the sex bias that has been observed in coronavirus disease 2019 (COVID-19). Reports have shown...
Post
Home health care improves COVID-19 outcomes
UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING PHILADELPHIA (November 23 2020) – Survivors of COVID-19 are a vulnerable population who often have health ramifications from their illness and hospital stay. Upon returning home from acute care, large proportions of survivors experience functional dependencies, pain, dyspnea, and exhaustion. Until now, no data has been available on the...
Post
Could beta-blockers be a potential treatment for COVID-19?
Thought LeadersDr. Nirmal RobinsonDr. Vincenzo DesiderioDr. Antonio Barbieri News-Medical spoke to researchers Dr. Nirmal Robinson, Dr. Vincenzo Desiderio, and Dr. Antonio Barbieri about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19. What provoked your research into the current COVID-19 pandemic? We have been working on adrenergic receptors for...
Post
Drug to reduce bleeding could treat COVID-19
Drug to reduce bleeding could treat COVID-19 A recent study has shown that aprotinin, a drug that reduces the risk of bleeding during surgery, can stop the novel coronavirus from entering host cells. The drug could serve to prevent severe cases of COVID-19, the authors say. Share on PinterestImage credit: MirageC / Getty Images. With...